Forge Therapeutics, Inc., a biotechnology company discovering first-in-class therapeutics using a breakthrough drug discovery platform, announced today that Zachary A. Zimmerman, Ph.D., CEO of...

Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced its participation...

IRIDEX Corporation (Nasdaq: IRIX) is pleased to announce the availability of the G-Probe™ Illuminate, a new, FDA-cleared probe offering combined transillumination and laser fiber for targeted...

Trovagene, Inc. (NASDAQ: TROV), a developer of circulating tumor DNA (ctDNA) molecular diagnostics, is scheduled to attend the 29th Annual ROTH Conference, March 12-15, 2017, at the Ritz Carlton...

Sherri Wu, the Chief Strategy Officer of VoyageOne and a former Alibaba executive, is presenting "Unlocking China's E-Commerce Opportunity" at Catalyst Americas 2017. This session is geared toward...